WeVote
Log In

Bill

Bill

HB 1220

Mississippi Hemoglobin A1c Screening Coverage Act; create and require health insurance coverage for.

2025 Regular Session

Mississippi bill would require health insurers to cover hemoglobin A1c diabetes screening tests at no cost to patients, died in committee in February 2025.

Died In Committee
#insurance #publichealthandhumanservices
0
WeVote Research Nonpartisan
Bill Summary · HB 1220

Legislative bill overview

HB 1220 would have mandated that health insurance plans in Mississippi cover hemoglobin A1c screening tests without cost-sharing requirements. The bill aimed to ensure early detection of prediabetes and diabetes by removing financial barriers to this diagnostic test.

Why is this important

Hemoglobin A1c screening identifies blood sugar control over a 2-3 month period and is critical for early diabetes detection, which affects over 37 million Americans and costs the healthcare system billions annually. Removing screening costs can increase testing rates, particularly among underinsured populations, potentially preventing serious complications like heart disease, kidney failure, and vision loss.

Potential points of contention

  • Insurance cost impact: Insurers may argue that mandating coverage without cost-sharing increases premiums for all enrollees, and question whether A1c screening frequency requirements are evidence-based
  • Coverage scope ambiguity: Unclear whether the mandate would cover screening for all adults or only high-risk populations, and how frequently tests could be ordered
  • Existing coverage: Many insurance plans already cover A1c screening; the necessity of legislation versus voluntary insurer coverage decisions may be disputed

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.